Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
10 studies found for:    Open Studies | "Pyelonephritis"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Sitafloxacin and Ertapenem Treatment for Acute Pyelonephritis Caused by Escherichia Coli
Conditions: Infection Due to Escherichia Coli;   Acute Pyelonephritis
Interventions: Drug: Sitafloxacin;   Drug: Ertapenem
2 Recruiting Study of Ceftolozane/Tazobactam (MK-7625A) in Japanese Participants With Uncomplicated Pyelonephritis and Complicated Urinary Tract Infection (MK-7625A-014)
Conditions: Urinary Tract Infection (UTI);   Complicated Urinary Tract Infection;   Pyelonephritis;   Uncomplicated Pyelonephritis
Intervention: Drug: MK-7625A 1.5 g (ceftolozane 1 g/tazobactam 0.5 g)
3 Recruiting Proteinuria During Acute Pyelonephritis In Pregnancy
Condition: Proteinuria
Intervention: Other: Exposure to pyelonephritis
4 Recruiting Antibiotic Treatment Versus no Therapy in Kidney Transplant Recipients With Asymptomatic Bacteriuria
Conditions: Asymptomatic Bacteriuria;   Pyelonephritis
Interventions: Drug: Antibiotic treatment;   Other: No treatment
5 Recruiting Pharmacokinetics of Ciprofloxacin in Pediatric Patients
Conditions: Urinary Tract Infection;   Pyelonephritis
Intervention: Drug: ciprofloxacin
6 Recruiting Special Drug Use Investigation of Ciproxan Injection in Pediatrics
Condition: Cystitis / Pyelonephritis / Cystic Fibrosis / Anthrax
Intervention: Drug: Cipro (Ciprofloxacin, BAYQ3939)
7 Recruiting Safety and Efficacy of ZTI-01 (IV Fosfomycin) vs Piperacillin/Tazobactam for Treatment cUTI/AP Infections
Conditions: Urinary Tract Infection Symptomatic;   Acute Pyelonephritis;   Urinary Tract Infection Complicated
Interventions: Drug: ZTI-01;   Drug: Piperacillin-tazobactam
8 Recruiting Cranberry-lingonberry Juice Started During Acute Infection in Prevention of Urinary Tract Infections in Children
Conditions: Urinary Tract Infection;   Pyelonephritis;   Cystitis
Interventions: Other: Cranberry-lingonberry juice;   Other: Placebo juice
9 Recruiting Efficacy, Safety, Tolerability of Carbavance Compared to Best Available Therapy in Serious Infections Due to Carbapenem Resistant Enterobacteriaceae, in Adults
Conditions: Urinary Tract Infection Complicated;   Acute Pyelonephritis;   Hospital Acquired Bacterial Pneumonia;   Ventilator-associated Bacterial Pneumonia;   Bacteremia
Interventions: Drug: Carbavance;   Drug: Best Available Therapy
10 Recruiting Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Conditions: Infection;   Hypertension;   Pain;   Reflux;   Edema;   Hyperlipidemia;   Hypotension;   Hypercholesterolemia;   Sedation;   Anxiolysis;   Benzodiazepine Withdrawal;   Bipolar Disorder;   Autistic Disorder;   Schizophrenia;   Influenza Treatment or Prophylaxis;   Acute Decompensated Heart Failure;   Stable Angina;   Life-threatening Fungal Infections;   Nosocomial Pneumonia;   Community Acquired Pneumonia;   Acute Bacterial Exacerbation of Chronic Bronchitis;   Complicated Skin and Skin Structure Infections;   Uncomplicated Skin and Skin Structure Infections;   Chronic Bacterial Prostatitis;   Complicated Urinary Tract Infections;   Acute Pyelonephritis;   Uncomplicated Urinary Tract Infections;   Inhalational Anthrax (Post-Exposure);   Infantile Hemangioma;   Withdrawal;   Inflammation;   Bacterial Septicemia;   Cytomegalovirus Retinitis;   Herpes Simplex Virus;   Adenovirus;   Brain Swelling;   Airway Swelling;   Adrenal Insufficiency;   Anxiety;   Nausea;   Vomiting;   Convulsions;   Muscle Spasms;   Seizures;   Epilepsy;   Bartonellosis;   Brucellosis;   Cholera;   Plague;   Psittacosis;   Q Fever;   Relapsing Fever;   Rocky Mountain Spotted Fever;   Trachoma;   Tularemia;   Typhus Fever;   Bronchospasm;   Cardiac Arrest;   Hypersensitivity Reaction;   Cyanide Poisoning;   Acute Bacterial Sinusitis;   Bacterial Meningitis;   Sepsis;   Gastroparesis;   Opioid Addiction;   Migraines;   Headaches
Intervention: Drug: The POPS study is collecting PK data on children prescribed the following drugs of interest per standard of care:

Study has passed its completion date and status has not been verified in more than two years.